Trials / Completed
CompletedNCT00135161
Feasibility Study of Incorporating 18F-FDG-PET Imaging in Radiotherapy for Head and Neck Cancer
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- University Hospital, Ghent · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to study fluorodeoxyglucose-positron emission tomography (FDG-PET)-based dose escalation using intensity modulated radiation therapy (IMRT).
Detailed description
The dose escalation, based on the FDG-PET signal, is incorporated in the first ten fractions of the radiotherapeutic treatment. The total amount of fractions is 32, equal to a standard radiotherapeutic treatment for these types of cancers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | FDG-PET-based dose escalation using intensity modulated radiation therapy (IMRT). | FDG-PET-based dose escalation using intensity modulated radiation therapy (IMRT). |
Timeline
- Start date
- 2003-09-01
- Primary completion
- 2015-08-01
- Completion
- 2015-08-01
- First posted
- 2005-08-25
- Last updated
- 2022-12-08
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00135161. Inclusion in this directory is not an endorsement.